Search For "biotech"
Rajesh S Gokhale gets addl charge of DG Council of Scientific and Industri
Updated : 3 years, 10 months ago IST
New Delhi [India], April 29 (ANI): Secretary of Department of Biotechnology Rajesh S Gokhale on Friday was given additional charge of the post of Director-General, Council of Scientific and Industrial Research (CSIR)-cum-Secretary, Department of Scientific and Industrial Research.
Read More
'Portrays incorrect picture', MEA on reports of it asking Bharat Biotech t
Updated : 3 years, 10 months ago IST
New Delhi [India], April 29 (ANI): The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval (EUA) nod for its COVID jab, "potra
Read More
Technicolor Creative Studios brings the world of AVGC to Bengaluru GAFX 20
Updated : 3 years, 10 months ago IST
Bengaluru (Karnataka) [India], April 28 (ANI/NewsVoir): Technicolor Creative Studios (TCS), a pioneer in the animation, gaming, and VFX sector, will bring its expertise and thought leadership to the upcoming Bengaluru GAFX 2022 - India's premier event on Animation, Visual Effects, Gaming and
Read More
Paediatricians welcome COVID vaccines for kids, say parents mustn't hesita
Updated : 3 years, 10 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
Updated : 3 years, 10 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.
Read More
FDA approves Direct Biologics to proceed with a Landmark Phase 3 Acute Res
Updated : 3 years, 10 months ago IST
Austin (Texas) [US], April 22 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigatio
Read More
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for
Updated : 3 years, 10 months ago IST
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.
Read More
Expert panel of DCGI holds meet to discuss recommendations to use COVID-19
Updated : 3 years, 10 months ago IST
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged
Read More
COVID pandemic has thrown open new challenges & opportunities for the
Updated : 3 years, 11 months ago IST
Chandigarh (Punjab) [India], April 19 (ANI/PR Newswire): "The situation of crisis throws open new challenges and opportunities and the global Covid-19 pandemic has once again proved that the science of Biotechnology has the potential to change the world and make it a better place to live," s
Read More
Ocugen to commercialize Covaxin in Mexico, rights now encompassing all of
Updated : 3 years, 11 months ago IST
Malvern (Pennsylvania) [US]/ Hyderabad (Telangana) [India], April 18 (ANI): Biotechnology company Ocugen and Bharat Biotech (BBIL), on Monday, announced that they have entered into an amendment to their Co-development, Supply and Commercialization Agreement to expand Ocugen's exclusive terri
Read More
FDA grants Direct Biologics regenerative Medicine Advanced Therapy (RMAT)
Updated : 3 years, 11 months ago IST
Austin (Texas) [US], April 13 (ANI/PRNewswire): Direct Biologics, an innovative biotechnology company with a groundbreaking extracellular vesicle (EV) platform drug technology, announced that the U.S. Food and Drug Administration (FDA) has awarded their EV drug product ExoFlo with a Regenera
Read More